BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2026 8:18:29 AM | Browse: 6 | Download: 30
 |
Received |
|
2026-02-07 03:07 |
|
Peer-Review Started |
|
2026-02-07 03:07 |
|
First Decision by Editorial Office Director |
|
2026-02-09 09:28 |
|
Return for Revision |
|
2026-02-09 09:28 |
|
Revised |
|
2026-02-10 07:26 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-27 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-27 07:15 |
|
Articles in Press |
|
2026-02-27 07:15 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-24 00:43 |
|
Publish the Manuscript Online |
|
2026-05-13 08:18 |
| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Review |
| Article Title |
Pediatric migraine: Neurodevelopmental mechanisms, clinical phenotypes, and modern therapeutics
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohammed Al-Beltagi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohammed Al-Beltagi, Chairman, Consultant, Head, MD, PhD, Professor, Department of Pediatrics, Faculty of Medicine, Tanta University, No. 1 Hassan Radwan Street, Tanta 31511, Algharbia, Egypt. mbelrem@hotmail.com |
| Key Words |
Pediatric migraine; Episodic syndromes; Migraine equivalents; Diagnosis; Neuromodulation devices; Calcitonin gene-related peptide monoclonal antibodies; Gepants |
| Core Tip |
Pediatric migraine is a common yet underrecognized neurodevelopmental disorder with age-specific clinical phenotypes, mechanisms, and treatment responses. Children are not “small adults”; migraine expression evolves with brain maturation, hormonal changes, and sensory processing, necessitating pediatric-specific diagnostic and therapeutic strategies. Early recognition of migraine equivalents, timely access to acute treatment, and avoidance of medication overuse are essential to prevent chronification. While traditional preventives offer limited efficacy, emerging mechanism-based therapies and neuromodulation devices are reshaping care. A multimodal, individualized approach integrating pharmacologic, behavioral, and educational interventions is critical to improving long-term outcomes. |
| Publish Date |
2026-05-13 08:18 |
| Citation |
Al-Beltagi M. Pediatric migraine: Neurodevelopmental mechanisms, clinical phenotypes, and modern therapeutics. World J Clin Pediatr 2026; 15(2): 119843 |
| URL |
https://www.wjgnet.com/2219-2808/full/v15/i2/119843.htm |
| DOI |
https://dx.doi.org/10.5409/wjcp.v15.i2.119843 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
